Form 4 for PHR Phreesia, Inc.
Accepted 2024-09-20 00:00:00 ET · period of report 2024-09-19 · accession 0001127602-24-024288 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-09-20 | 2024-09-19 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.04 | -24 | 8,971 | -0.3% | -$576.96 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-19 | S | D | 24 | $24.04 | 8,971 | I By Spouse | — | — |